Alamar Biosciences, Inc. (California) (ALMR)
30.83
-0.93
(-2.93%)
USD |
NASDAQ |
Nov 13, 16:00
30.83
0.00 (0.00%)
After-Hours: 19:59
Alamar Biosciences Debt to Equity Ratio : 0.1394 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.1394 |
| June 30, 2026 | 0.1643 |
| Date | Value |
|---|---|
| March 31, 2026 | -1.912 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Personalis, Inc. | 0.1749 |
| 10X Genomics, Inc. | 0.0904 |
| Champions Oncology, Inc. | 2.818 |
| Medpace Holdings, Inc. | 0.2931 |
| Avantor, Inc. | 0.6312 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 378.03M |
| Total Liabilities (Quarterly) | 74.32M |
| Shareholders Equity (Quarterly) | 303.70M |
| Current Ratio | 9.488 |
| Net Debt Paydown Yield | -0.36% |